🔴 Sana Biotechnology is trading 5% down as biotech shares weaken amid risk-off sentiment

Sana Biotechnology is trading 5.06% lower at $2.25 as biotech and broader markets weaken amid risk-off sentiment and geopolitical concerns; no clear company-specific catalyst surfaced in available news results.

• The supplied sector context shows XBI down 2.08%.
• One market overview also reported no company-specific catalyst for the decline.